Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …

Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of
cancer of the prostate is very important, because the sooner the cancer is detected, the …

The identification of biomarkers indicating the level of aggressiveness of prostate cancer
(PCa) will address the urgent clinical need to minimize the general overtreatment of patients …

BACKGROUND The key to a more effective diagnosis, prognosis, and therapeutic
management of prostate cancer (PCa) could lie in the direct analysis of cancer tissue. In this …

Proteomics and metabolomics investigations of body fluids present several challenges for
biomarker discovery of several diseases. The search for biomarkers is actually conducted in …

This paper presents a review of the importance and role of precision medicine and
molecular imaging technologies in cancer diagnosis with therapeutics and diagnostics …

Advances in our understanding of the mechanisms driving castration-resistant prostate
cancer have promoted the development of several new drugs including androgen receptor …

The clinical and fundamental research in prostate cancer-the most common urological
cancer in men-is currently entering the proteomic and genomic era. The focus has switched …

Following the introduction of routine Prostate Specific Antigen (PSA) screening in the early
1990′ s, Prostate Cancer (PCa) is often detected at an early stage. There are also a …

Despite the overall success of prostate specific antigen (PSA) in screening and detection of
prostate cancer (PCa), its use has been limited due to the lack of specificity. The principal …